Clinical Trials Browser

Recurrence × irinotecan sucrosofate × 90 days × Clear all

NCT07444918 2026-03-03

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Phase 2 Not yet recruiting

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma